Skip to main content

Advertisement

Log in

Analysis of differential therapeutic strategies for primary breast lymphoma: two case reports

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Primary breast lymphoma (PBL) is a rare form of extranodal non-Hodgkin’s lymphoma (NHL), whose own specific biological characteristics still need to be fully defined. No significant prognostic factor has been found and the optimal therapeutic strategy is uncertain. However, an intensified systemic therapy has been advocated to prevent relapse, even in patients who show a complete response to local treatment. We report two cases of primary diffuse large B-cell breast lymphoma, review the literature about this topic, and discuss treatment options. We conclude that differential therapeutic strategies based on the risk of relapse associated with the International Prognostic Index (IPI) are a reasonable way to approach PBL, and can avoid undue toxicity deriving from treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

PBL:

Primary breast lymphoma

NHL:

Non Hodgkin’s lymphoma

CNS:

Central nervous system

IPI:

International Prognostic Index

LDH:

Lactate dehydrogenase

ECOG:

Eastern Cooperative Oncology Group

CHOP:

Cyclophosphamide, doxorubicin, vincristine, and prednisolone

References

  1. Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44:1173–8.

    Article  PubMed  CAS  Google Scholar 

  2. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.

    Article  PubMed  CAS  Google Scholar 

  3. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement. Cancer. 2002;94:6–13.

    Article  PubMed  Google Scholar 

  4. Barista I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozisik Y, et al. Primary breast lymphomas-a retrospective analysis of twelve cases. Acta Oncol. 2000;39:135–9.

    Article  PubMed  CAS  Google Scholar 

  5. Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.

    PubMed  CAS  Google Scholar 

  6. Ryan GF, Martinelli G, Yuen K, Seymour J. Primary non-Hodgkin’s lymphoma of the breast: first report of the multicentre retrospective study of the International Extranodal Lymphoma Study Group (IELSG-15). J Clin Oncol. 2005;16:6575a.

    Google Scholar 

  7. Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol. 2005;18:398–405.

    Article  PubMed  CAS  Google Scholar 

  8. Liberman L, Giess CS, Dershaw DD, Louie DC, Deutch BM. Non-Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Radiology. 1994;192:157–60.

    PubMed  CAS  Google Scholar 

  9. Lieberman HB. DNA damage repair and response proteins as targets for cancer therapy. Curr Med Chem. 2008;15:360–7.

    Article  PubMed  CAS  Google Scholar 

  10. Krishnan B, Morgan GJ. Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev. 2007;16:377–80.

    Article  PubMed  CAS  Google Scholar 

  11. Duncan VE, Reddy VV, Jhala NC, Chhieng DC, Jhala DN. Non-Hodgkin’s lymphoma of the breast: a review of 18 primary and secondary cases. Ann Diagn Pathol. 2006;10:144–8.

    Article  PubMed  Google Scholar 

  12. Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66:2602–11.

    Article  PubMed  CAS  Google Scholar 

  13. Zinzani PL, Magagnoli M, Frezza G, Prologo G, Gherlinzoni F, Bendandi M, et al. Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience. Leuk Lymphoma. 1999;32:571–6.

    PubMed  CAS  Google Scholar 

  14. Tondini C, Ferreri AJ, Siracusano L, Valagussa P, Giardini R, Rampinelli I, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol. 1999;17:2854–8.

    PubMed  CAS  Google Scholar 

  15. National Comprehensive Cancer Network. Non-Hodgkin’s Lymphoma V.3.2007. NCCN Clinical Practice Guidelines in Oncology 2007: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf. Accessed 28 Dec 2007.

  16. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac, pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.

    Article  PubMed  CAS  Google Scholar 

  17. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465–75.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Stasi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stasi, R., Evangelista, M.L., Brunetti, M. et al. Analysis of differential therapeutic strategies for primary breast lymphoma: two case reports. Med Oncol 26, 22–26 (2009). https://doi.org/10.1007/s12032-008-9073-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-008-9073-z

Keywords

Navigation